Private Capital Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $233K | Sell |
3,005
-4,664
| -61% | -$362K | 0.18% | 111 |
|
|
2022
Q1 | $564K | Buy |
7,669
+375
| +5% | +$27.6K | 0.13% | 100 |
|
|
2021
Q4 | $455K | Sell |
7,294
-1,218
| -14% | -$76K | 0.1% | 133 |
|
|
2021
Q3 | $508K | Buy |
8,512
+120
| +1% | +$7.16K | 0.11% | 116 |
|
|
2021
Q2 | $561K | Buy |
8,392
+683
| +9% | +$45.7K | 0.13% | 107 |
|
|
2021
Q1 | $490K | Sell |
7,709
-2,657
| -26% | -$169K | 0.12% | 110 |
|
|
2020
Q4 | $648K | Sell |
10,366
-526
| -5% | -$32.9K | 0.12% | 130 |
|
|
2020
Q3 | $657K | Buy |
10,892
+990
| +10% | +$59.7K | 0.14% | 117 |
|
|
2020
Q2 | $582K | Buy |
9,902
+227
| +2% | +$13.3K | 0.13% | 124 |
|
|
2020
Q1 | $539K | Buy |
9,675
+71
| +0.7% | +$3.96K | 0.14% | 113 |
|
|
2019
Q4 | $616K | Sell |
9,604
-3,605
| -27% | -$231K | 0.13% | 108 |
|
|
2019
Q3 | $670K | Buy |
13,209
+2,856
| +28% | +$145K | 0.12% | 114 |
|
|
2019
Q2 | $573K | Sell |
10,353
-3,596
| -26% | -$199K | 0.13% | 112 |
|
|
2019
Q1 | $666K | Buy |
13,949
+109
| +0.8% | +$5.2K | 0.13% | 110 |
|
|
2018
Q4 | $719K | Buy |
13,840
+1,408
| +11% | +$73.1K | 0.16% | 102 |
|
|
2018
Q3 | $771K | Buy |
12,432
+1,495
| +14% | +$92.7K | 0.15% | 105 |
|
|
2018
Q2 | $605K | Sell |
10,937
-115
| -1% | -$6.36K | 0.13% | 115 |
|
|
2018
Q1 | $699K | Buy |
11,052
+228
| +2% | +$14.4K | 0.16% | 103 |
|
|
2017
Q4 | $663 | Buy |
+10,824
| New | +$663 | 0.16% | 101 |
|